RGN-137-EB-202: A Randomized, Single-Blind, Placebo-controlled, Selfmatchedpairing, Independent evaluated Study to Evaluatethe Efficacy and Safety of 0.03% RGN-137 Topical Gel inSubjects with Junctional and Dystrophic Epi

Project: Research project

Project Details

StatusActive
Effective start/end date6/18/198/31/50

Funding

  • Northwestern University
  • Lenus Therapeutics